In the French population, the frequency of tissue somatic alterations reported in patients with NSCLC is 11% in EGFR, 1% in HER2, 29% in KRAS, 2% in BRAF, and 2% in PIK3CA [53]. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.